
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : SARS-CoV-2 mRNA Vaccine,CVnCoV
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : CureVac
Deal Size : Undisclosed
Deal Type : Agreement
CureVac and Fareva Sign Agreement for Filling and Packaging of CureVac COVID19 Vaccine Candidate
Details : Under the agreement, Fareva will fill & finish manufacturing of CureVac´s COVID-19 vaccine candidate, CVnCoV, a COVID-19 vaccine candidate developed by CureVac, in France.
Product Name : CVnCoV
Product Type : Vaccine
Upfront Cash : Undisclosed
December 08, 2020
Lead Product(s) : SARS-CoV-2 mRNA Vaccine,CVnCoV
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : CureVac
Deal Size : Undisclosed
Deal Type : Agreement
